Publications scientifiques sur le VIH
Ibalizumab: an anti-CD4 monoclonal antibody for the treatment of HIV-1 infection.
2010
J Antimicrob Chemother.
Bruno CJ, Jacobson JM.
65(9):1839-1841.
Crystal structure of HIV-1 primary receptor CD4 in complex with a potent antiviral antibody.
2010
Structure.
Freeman MM, Seaman MS, Rits-Volloch S, et al.
18(12):1632-1641.
Epitope mapping of ibalizumab, a humanized anti-CD4 monoclonal antibody with anti-HIV-1 activity in infected patients.
2010
J Virol.
Song R, Franco D, Kao C-Y, et al.
84(14):6935-6942.
Reduction in visceral adipose tissue (VAT) with tesamorelin correlates with changes in anthropometric, and patient-reported outcome (PRO) parameters in HIV+ patients with excess abdominal fat.
2010
Falutz J, Michaud SE, Morin J, et al.
Poster #H-227 presented at: 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); September 12-15, 2010; Boston, Massachusetts, USA.
Efficacy and long-term safety of tesamorelin (TH9507), a growth hormone-releasing factor (GRF) analogue, in sub-populations of HIV-infected patients with excess abdominal fat.
2010
Zoltowska M, Morin J, Glyman S, Soulban G.
Poster #H-228 presented at: 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); September 12-15, 2010; Boston, Massachusetts, USA.